Harmony Biosciences Holdings, Inc. (HRMY)

NASDAQ: HRMY · Real-Time Price · USD

42.02

-0.72 (-1.68%)

At close: Sep 18, 2026, 4:00 PM EDT

41.00

-1.02 (-2.43%)

After-hours: Sep 18, 2026, 7:30 PM EDT

HRMY Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 18, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	2,447	2,155	1,962	1,892	3,268	2,493
Market Cap Growth	32.67%	9.83%	3.73%	-42.12%	31.09%	21.23%
Enterprise Value	1,939	1,652	1,737	1,721	3,155	2,496
Last Close Price	42.02	37.42	34.41	32.30	55.10	42.64

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 18, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	13.59	13.58	13.49	14.68	18.01	72.07
Forward PE	10.49	10.05	11.82	11.14	23.01	25.27
PS Ratio	2.55	2.48	2.75	3.25	7.47	8.16
PB Ratio	2.44	2.48	2.98	4.05	8.11	13.37
P/TBV Ratio	2.65	2.76	3.60	5.74	13.51	58.54
P/FCF Ratio	6.90	6.20	8.98	8.64	22.65	25.37
P/OCF Ratio	6.89	6.19	8.93	8.62	22.62	25.30
PEG Ratio	0.37	0.39	0.47	0.73	-	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 18, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	2.02	1.90	2.43	2.96	7.21	8.17
EV/EBITDA Ratio	7.58	7.07	8.08	7.95	21.98	23.46
EV/EBIT Ratio	8.41	7.93	9.10	8.96	26.25	28.51
EV/FCF Ratio	5.46	4.75	7.95	7.86	21.87	25.40

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 18, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.16	0.19	0.28	0.42	0.48	1.05
Debt / EBITDA Ratio	0.62	0.72	0.84	0.90	1.34	1.82
Debt / FCF Ratio	0.45	0.49	0.83	0.90	1.35	1.99
Net Debt / Equity Ratio	-0.51	-0.70	-0.43	-0.34	-0.32	-0.21
Net Debt / EBITDA Ratio	-1.98	-2.59	-1.33	-0.73	-0.90	-0.36
Net Debt / FCF Ratio	-1.43	-1.74	-1.31	-0.72	-0.89	-0.39
Asset Turnover	0.77	0.77	0.79	0.78	0.79	0.71
Inventory Turnover	37.87	31.60	24.97	25.10	19.13	13.45
Quick Ratio	3.33	3.46	3.14	2.61	4.79	5.01
Current Ratio	3.48	3.60	3.31	2.75	5.07	5.29
Return on Equity (ROE)	20.46%	20.75%	25.84%	29.63%	61.58%	24.39%
Return on Assets (ROA)	11.62%	11.47%	13.17%	16.16%	13.57%	12.71%
Return on Invested Capital (ROIC)	37.45%	48.26%	42.39%	48.91%	56.97%	76.78%
Return on Capital Employed (ROCE)	20.30%	20.40%	23.20%	29.60%	20.20%	23.10%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 18, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	7.41%	7.36%	7.41%	6.81%	5.55%	1.39%
FCF Yield	14.50%	16.14%	11.14%	11.58%	4.42%	3.94%
Buyback Yield / Dilution	-0.65%	-1.17%	4.15%	1.19%	-3.19%	-129.72%

SEC Filings: 10-K · 10-Q